This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...

An experimental gene therapy that involves injecting CRISPR therapy directly into visually impaired patients’ eyeballs has vastly improved most volunteers’ vision — even allowing some to see color ...

Genetic diseases are a compelling target for viral gene therapy, but the results can be spotty at best. There's good news, though. On Wednesday, researchers presented evidence from a breakthrough gene ...

Genetic diseases are a compelling target for viral gene therapy, but the results can be spotty at best. There's good news, though. On Wednesday, researchers presented evidence from a breakthrough gene ...

Currently, there is no cure available for color vision deficiency that is present from birth. However, supportive tools, such as glasses, contacts, and visual aids, can help people navigate color ...

One of the ways scientists hope to offer better treatments for vision loss is through gene therapy, where carefully selected genetic material is injected into the eyes to address mutations.

The most common types of color blindness, or color vision deficiency, are genetic. However, other types may develop due to injuries, eye diseases, health problems, and side effects of treatment.

BERKELEY, Calif.--(BUSINESS WIRE)--EnChroma, Inc. – the leader in color vision solutions – today announced the EnChroma® Lx Lens Technology, a new lens series and eyewear designed for low vision and ...

Color is more than a sensory pleasure; it is a tool refined by evolution. Our ability to perceive a broad spectrum of hues is a remarkable biological achievement shaped by survival pressures, social ...